In vivo therapeutic efficacy of TNFα silencing by folate-PEG-chitosan-DEAE/siRNA nanoparticles in arthritic mice

References

• AsquithDLMillerAMMcInnesIBAnimal models of rheumatoid arthritisEur J Immunol20093982040204419672892
   PubMed Web of Science ®Google Scholar
• YeCBhanADeshpandeVSilencing TNF-α in macrophages and dendritic cells for arthritis treatmentScand J Rheumatol201342426626923582054
   PubMed Web of Science ®Google Scholar
• MarenzanaMVuglerAMooreARobinsonMEffect of sclerostin-neutralising antibody on periarticular and systemic bone in a murine model of rheumatoid arthritis: a microCT studyArthritis Res Ther2013155R12524432364
   PubMed Web of Science ®Google Scholar
• ScottDPrognostic factors in early rheumatoid arthritisRheumatology (Oxford, England)2000392429
   PubMed Web of Science ®Google Scholar
• GoldringSRGravalleseEMMechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implicationsArthritis Res200021333711094416
   PubMedGoogle Scholar
• WilliamsROFeldmannMMainiRNAnti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritisProc Natl Acad Sci U S A19928920978497881409699
   PubMed Web of Science ®Google Scholar
• PaquetJHenrionnetCPinzanoAAlternative for anti-TNF antibodies for arthritis treatmentMol Ther201119101887189521811249
   PubMed Web of Science ®Google Scholar
• BuchMHPavittSParmarMEmeryPCreative trial design in RA: optimizing patient outcomesNat Rev Rheumatol20139318319423381561
   PubMed Web of Science ®Google Scholar
• van SchouwenburgPARispensTWolbinkGJImmunogenicity of anti-TNF biologic therapies for rheumatoid arthritisNat Rev Rheumatol20139316417223399692
   PubMed Web of Science ®Google Scholar
• BenderATSpyveeMSatohTEvaluation of a candidate anti-arthritic drug using the mouse collagen antibody induced arthritis model and clinically relevant biomarkersAm J Transl Res2013519223390569
   PubMed Web of Science ®Google Scholar
• MehtaGScheinmanRIHolersVMBandaNKA new approach for the treatment of arthritis in mice with a novel conjugate of an anti-C5aR1 antibody and C5 small interfering RNAJ Immunol2015194115446545425917104
   PubMed Web of Science ®Google Scholar
• HamamuraKNishimuraAChenASalubrinal acts as a Dusp2 inhibitor and suppresses inflammation in anti-collagen antibody-induced arthritisCell Signal201527482883525619567
   PubMed Web of Science ®Google Scholar
• SchiffelersRMXuJStormGEffects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritisArthritis Rheum20055241314131815818667
   PubMed Web of Science ®Google Scholar
• ShiQTieraMJZhangXChitosan-DNA/siRNA nanoparticles for gene therapyNon-Viral Gene Ther201119455480
   Google Scholar
• TieraMJShiQBarbosaHFFernandesJCPolymeric systems as nanodevices for siRNA deliveryCurr Gene Ther201313535836924369060
   PubMed Web of Science ®Google Scholar
• XiangSSuJTongHBiscarbamate cross-linked low molecular weight PEI for delivering IL-1 receptor antagonist gene to synoviocytes for arthritis therapyBiomaterials201233276520653222695070
   PubMed Web of Science ®Google Scholar
• CastanottoDRossiJJThe promises and pitfalls of RNA-interference-based therapeuticsNature2009457722842643319158789
   PubMed Web of Science ®Google Scholar
• GaryDJPuriNWonYYPolymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA deliveryJ Control Release20071211–2647317588702
   PubMed Web of Science ®Google Scholar
• GaoXKimKSLiuDNonviral gene delivery: what we know and what is nextAAPS J200791E92E10417408239
   PubMed Web of Science ®Google Scholar
• JooMKYheeJYKimSHKimKThe potential and advances in RNAi therapy: chemical and structural modifications of siRNA molecules and use of biocompatible nanocarriersJ Control Release201419311312124862319
   PubMed Web of Science ®Google Scholar
• AndersenMOHowardKAKjemsJRNAi using a chitosan/siRNA nanoparticle system: in vitro and in vivo applicationsMethods Mol Biol2009555778619495689
   PubMedGoogle Scholar
• HowardKAPaludanSRBehlkeMAChitosan/siRNA nanoparticle-mediated TNF-alpha knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis modelMol Ther200917116216818827803
   PubMed Web of Science ®Google Scholar
• LeeSJLeeAHwangSRTNF-alpha gene silencing using polymerized siRNA/thiolated glycol chitosan nanoparticles for rheumatoid arthritisMol Ther201422239740824145554
   PubMed Web of Science ®Google Scholar
• KatasHAlparHODevelopment and characterisation of chitosan nanoparticles for siRNA deliveryJ Control Release2006115221622516959358
   PubMed Web of Science ®Google Scholar
• FernandesJCWangHJreyssatyCBone-protective effects of nonviral gene therapy with Folate–Chitosan DNA nanoparticle containing Interleukin-1 receptor antagonist gene in rats with adjuvant-induced arthritisMol Ther20081671243125118500247
   PubMed Web of Science ®Google Scholar
• SudimackJLeeRJTargeted drug delivery via the folate receptorAdv Drug Deliv Rev200041214716210699311
   PubMed Web of Science ®Google Scholar
• YangCGaoSKjemsJFolic acid conjugated chitosan for targeted delivery of siRNA to activated macrophages in vitro and in vivoJ Mater Chem B201424886088615
   PubMed Web of Science ®Google Scholar
• OliveiraFdPPDalla PicolaIPShiQSynthesis and evaluation of diethylethylamine chitosan for gene delivery: composition effects on the in vitro transfection efficiencyNanotechnology201324505510123306549
   PubMed Web of Science ®Google Scholar
• de OliveiraPRTakakiMGorayebTCSynthesis, characterization and antifungal activity of quaternary derivatives of chitosan on Aspergillus flavusMicrobiol Res20131681505522819383
   PubMedGoogle Scholar
• KhachigianLMCollagen antibody-induced arthritisNat Protoc2006152512251617406499
   PubMed Web of Science ®Google Scholar
• ChoKCJeongJHChungHJFolate receptor-mediated intracellular delivery of recombinant caspase-3 for inducing apoptosisJ Control Release2005108112113116139916
   PubMed Web of Science ®Google Scholar
• FernandesJCQiuXWinnikFMLow molecular weight chitosan conjugated with folate for siRNA delivery in vitro: optimization studiesInt J Nanomedicine20127583323209368
   PubMed Web of Science ®Google Scholar
• YangCGaoSDagnaes-HansenFJakobsenMKjemsJImpact of PEG chain length on the physical properties and bioactivity of PEGylated chitosan/siRNA nanoparticles in vitro and in vivoACS Appl Mater Interfaces2017914122031221628332829
   PubMed Web of Science ®Google Scholar
• MalmoJSorgardHVarumKMStrandSPsiRNA delivery with chitosan nanoparticles: molecular properties favoring efficient gene silencingJ Control Release2012158226126822119955
   PubMed Web of Science ®Google Scholar
• Tavakoli NaeiniASolimanOYAlamehMGLavertuMBuschmannMDAutomated in-line mixing system for large scale production of chitosan-based polyplexesJ Colloid Interface Sci201750025326328411432
   PubMed Web of Science ®Google Scholar
• ShiQAbusarahJBaroudiGRamipril attenuates lipid peroxidation and cardiac fibrosis in an experimental model of rheumatoid arthritisArthritis Res Ther2012145R22323079082
   PubMed Web of Science ®Google Scholar
• WisłowskaMJakubiczDStępieńKCichaMSerum concentrations of formation (PINP) and resorption (Ctx) bone turnover markers in rheumatoid arthritisRheumatol Int200929121403140919219607
   PubMed Web of Science ®Google Scholar
• ShiQVaillancourtFCôtéVAlterations of metabolic activity in human osteoarthritic osteoblasts by lipid peroxidation end product 4-hydroxynonenalArthritis Res Ther200686R15917042956
   PubMed Web of Science ®Google Scholar
• BasDBSuJSandorKCollagen antibody-induced arthritis evokes persistent pain with spinal glial involvement and transient prostaglandin dependencyArthritis Rheum201264123886389622933386
   PubMedGoogle Scholar
• KirályKLapveteläinenTArokoskiJApplication of selected cationic dyes for the semiquantitative estimation of glycosaminoglycans in histological sections of articular cartilage by microspectrophotometryHistochem J19962885775908894661
   PubMedGoogle Scholar
• BoileauCMartel-PelletierJCaronJProtective effects of total fraction of avocado/soybean unsaponifiables on the structural changes in experimental dog osteoarthritis: inhibition of nitric oxide synthase and matrix metalloproteinase-13Arthritis Res Ther2009112R4119291317
   PubMed Web of Science ®Google Scholar
• IbanezLAlcarazMJMaicasNDownregulation of the inflammatory response by CORM-3 results in protective effects in a model of postmenopausal arthritisCalcif Tissue Int2012911698022644323
   PubMed Web of Science ®Google Scholar
• OestergaardSChouinardLDoyleNThe utility of measuring C-terminal telopeptides of collagen type II (CTX-II) in serum and synovial fluid samples for estimation of articular cartilage status in experimental models of destructive joint diseasesOsteoarthritis Cartilage200614767067916500121
   PubMed Web of Science ®Google Scholar
• RamprasathVRShanthiPSachdanandamPCurative effect of Semecarpus anacardium Linn. nut milk extract against adjuvant arthritis with special reference to bone metabolismChem Biol Interact2006160318319216513099
   PubMed Web of Science ®Google Scholar
• RomasEBakharevskiOHardsDKExpression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritisArthritis Rheum200043482110765926
   PubMedGoogle Scholar
• RojanarataTPetchsangsaiMOpanasopitPMethylated N-(4-N,N-dimethylaminobenzyl) chitosan for novel effective gene carriersEur J Pharm Biopharm200870120721418602802
   PubMed Web of Science ®Google Scholar
• LiuXHowardKADongMThe influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencingBiomaterials20072861280128817126901
   PubMed Web of Science ®Google Scholar
• LowPSAntonyACFolate receptor-targeted drugs for cancer and inflammatory diseasesAdv Drug Deliv Rev20045681055105815094205
   PubMed Web of Science ®Google Scholar
• TurkMJBreurGJWidmerWRFolate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritisArthritis Rheum20024671947195512124880
   PubMed Web of Science ®Google Scholar
• SmolenJSAletahaDKoellerMNew therapies for treatment of rheumatoid arthritisLancet200737096021861187417570481
   PubMed Web of Science ®Google Scholar
• WiensAVensonRCorrerCJMeta-analysis of the efficacy and safety of adalimumab, etanercept, and infliximab for the treatment of rheumatoid arthritisPharmacotherapy201030433935320334454
   PubMed Web of Science ®Google Scholar
• KomanoYTanakaMNankiTIncidence and risk factors for serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a report from the registry of Japanese rheumatoid arthritis patients for longterm safetyJ Rheumatol20113871258126421498482
   PubMed Web of Science ®Google Scholar
• KomanoYYagiNOnoueIArthritic joint-targeting small interfering RNA-encapsulated liposome: implication for treatment strategy for rheumatoid arthritisJ Pharmacol Exp Ther2012340110911321994423
   PubMed Web of Science ®Google Scholar
• BaimSMillerPDAssessing the clinical utility of serum CTX in postmenopausal osteoporosis and its use in predicting risk of osteonecrosis of the jawJ Bone Miner Res200924456157419257812
   PubMed Web of Science ®Google Scholar
• LiuWCYenJFLangCLBisphophonates in CKD patients with low bone mineral densitySci World J20132013837573
   Google Scholar
• LehmanMAKreamJBrogmaDAcid and alkaline phosphatase activity in the serum and synovial fluid of patients with arthritisJ Bone Joint Surg Am19644681732173814239861
   PubMed Web of Science ®Google Scholar
• RisteliLRisteliJAnalysis of extracellular matrix proteins in biological fluidsMethods Enzymol19871453914113600399
   PubMed Web of Science ®Google Scholar
• MelkkoJKauppilaSNiemiSImmunoassay for intact amino-terminal propeptide of human type I procollagenClin Chem1996426 Pt 19479548665688
   PubMed Web of Science ®Google Scholar
• LianJBGundbergCMOsteocalcin. Biochemical considerations and clinical applicationsClin Orthop Relat Res1988226267291
   PubMed Web of Science ®Google Scholar
• SeibelMMolecular markers of bone turnover: biochemical, technical and analytical aspectsOsteoporos Int20001118S18S2911193236
   PubMedGoogle Scholar
• SwaminathanRBiochemical markers of bone turnoverClinica Chimica Acta2001313195105
   PubMed Web of Science ®Google Scholar
• HauschkaPVLianJBColeDEGundbergCMOsteocalcin and matrix Gla protein: vitamin K-dependent proteins in bonePhysiol Rev198969399010472664828
   PubMed Web of Science ®Google Scholar
• GlowackiJReyCGlimcherMA role for osteocalcin in osteoclast differentiationJ Cell Biochem19914532923022066381
   PubMed Web of Science ®Google Scholar
• GundbergCMBiochemical markers of bone formationClin Lab Med200020348950110986617
   PubMed Web of Science ®Google Scholar
• DíazDEDíazMMde la PiedraCRapadoALack of correlation between levels of osteocalcin and bone alkaline phosphatase in healthy control and postmenopausal osteoporotic womenHorm Metab Res19952731511547607606
   PubMed Web of Science ®Google Scholar
• BikleDDBiochemical markers in the assessment of bone diseaseAm J Med199710354274369375712
   PubMed Web of Science ®Google Scholar
• JanckilaAJNeustadtDHNakasatoYRSerum tartrate-resistant acid phosphatase isoforms in rheumatoid arthritisClinica Chimica Acta200232014958
   PubMed Web of Science ®Google Scholar
• KawaiVKSteinCMPerrienDSGriffinMREffects of anti-tumor necrosis factor α (anti-TNF) agents on boneCurr Opin Rheumatol201224557622810364
   PubMed Web of Science ®Google Scholar
• WeitzmannMNThe role of inflammatory cytokines, the RANKL/OPG axis, and the immunoskeletal interface in physiological bone turnover and osteoporosisScientifica2013201312570524278766
   PubMedGoogle Scholar